The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Titan Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Titan Pharmaceuticals has a total shareholder equity of $2.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $3.1M and $263.0K respectively.
Short Term Liabilities: TTNP's short term assets ($3.1M) exceed its short term liabilities ($263.0K).
Long Term Liabilities: TTNP has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: TTNP is debt free.
Reducing Debt: TTNP has no debt compared to 5 years ago when its debt to equity ratio was 318.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TTNP has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TTNP has less than a year of cash runway if free cash flow continues to grow at historical rates of 24.2% each year.
Discover healthy companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2025/10/01 08:57
End of Day Share Price
2025/10/01 00:00
Earnings
2025/06/30
Annual Earnings
2024/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Titan Pharmaceuticals, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.